David A. Siegel Eyenovia, Inc. Transaction History

Two Sigma Advisers, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.71 - $3.26 $6,498 - $12,388	-3,800 Reduced 20.54%	14,700 $29,000
Q1 2022 May 16, 2022	SELL	$2.66 - $3.99 $15,960 - $23,940	-6,000 Reduced 24.49%	18,500 $56,000
Q4 2021 Feb 14, 2022	SELL	$3.5 - $6.58 $225,050 - $423,094	-64,300 Reduced 72.41%	24,500 $98,000
Q3 2021 Nov 15, 2021	SELL	$3.97 - $5.64 $383,899 - $545,388	-96,700 Reduced 52.13%	88,800 $435,000
Q2 2021 Aug 16, 2021	BUY	$4.36 - $5.75 $174,836 - $230,575	40,100 Added 27.58%	185,500 $920,000
Q1 2021 May 17, 2021	BUY	$5.11 - $7.41 $142,058 - $205,998	27,800 Added 23.64%	145,400 $743,000
Q4 2020 Feb 16, 2021	BUY	$3.11 - $6.06 $279,589 - $544,794	89,900 Added 324.55%	117,600 $713,000
Q3 2020 Nov 16, 2020	BUY	$2.61 - $5.1 $72,297 - $141,270	27,700 New	27,700 $86,000

13.4M

13.1K

21.3K

Ticker EYEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,212,900
Market Cap $3.42M
Description
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the develop...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.